kabutan

ASKA Pharmaceutical Holdings Co.,Ltd.(4886) Summary

4886
TSE Prime
ASKA Pharmaceutical Holdings Co.,Ltd.
1,933
JPY
-33
(-1.68%)
Dec 5, 3:13 pm JST
12.49
USD
Dec 5, 1:13 am EST
Result
PTS
outside of trading hours
1,930.1
Dec 5, 3:06 pm JST
Summary Chart Historical News Financial Result
PER
10.9
PBR
0.82
Yield
2.85%
Margin Trading Ratio
14.39
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
1,960 JPY 12.63 USD
Previous Close Dec 4
1,966 JPY 12.65 USD
High Dec 5, 9:48 am
1,965 JPY 12.66 USD
Low Dec 5, 2:05 pm
1,927 JPY 12.44 USD
Volume
36,100
Trading Value
0.07B JPY 0.45M USD
VWAP
1940.32 JPY 12.55 USD
Minimum Trading Value
193,300 JPY 1,249 USD
Market Cap
0.06T JPY 0.36B USD
Number of Trades
210
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
247
1-Year High Sep 1, 2025
3,060
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 12,700 122,200 9.62
Nov 21, 2025 9,600 122,800 12.79
Nov 14, 2025 11,500 134,400 11.69
Nov 7, 2025 23,800 134,800 5.66
Oct 31, 2025 3,000 125,900 41.97
Company Profile
ASKA Pharmaceutical Holdings Co., Ltd. specializes in gynecology and urology, with hormone preparations as its main products. The company sells generic drugs for Takeda and also develops new drugs.
Sector
Pharmaceuticals
ASKA Pharmaceutical Holdings Co., Ltd. focuses on the pharmaceutical business as its core, while also operating in animal health and clinical testing sectors. In the pharmaceutical business, "Aska Pharmaceutical" specializes in products for internal medicine, obstetrics and gynecology, and urology, which are distributed through Takeda Pharmaceutical Company. The animal health business is managed by "Aska Animal Health," which procures some products from Aska Pharmaceutical while also outsourcing manufacturing to Aska Pharmaceutical. The clinical testing business is operated by "Aska Pharmaceutical Medical," which leases facilities from Aska Pharmaceutical for its operations. Additionally, Aska Pharmaceutical handles the procurement and sales of medical devices and health foods. The company has adopted a holding company structure to manage its group companies effectively.